Lv1
20 积分 2024-03-20 加入
Resmetirom for treatment of MASH
5天前
已完结
Cytotoxicity of Thirdhand Smoke and Identification of Acrolein as a Volatile Thirdhand Smoke Chemical That Inhibits Cell Proliferation
1个月前
已完结
Thyroid Hormone Signaling and the Liver
5个月前
已完结
Non-alcoholic fatty liver disease
6个月前
已完结
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
6个月前
已完结
First US drug approved for a liver disease surging around the world
7个月前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
7个月前
已完结
Resmetirom proves positive for NASH with liver fibrosis
7个月前
已完结
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
7个月前
已完结
A researcher’s guide to preclinical mouse NASH models
7个月前
已完结
皖公网安备34019202002308
